541 related articles for article (PubMed ID: 29198021)
1. Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.
Kumar V; Singh D; Singh BK; Singh S; Mittra N; Jha RR; Patel DK; Singh C
Mol Cell Biochem; 2018 Jul; 444(1-2):149-160. PubMed ID: 29198021
[TBL] [Abstract][Full Text] [Related]
2. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
3. Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells.
Xie H; Wu J
Chem Biol Interact; 2016 Oct; 258():197-204. PubMed ID: 27613482
[TBL] [Abstract][Full Text] [Related]
4. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
[TBL] [Abstract][Full Text] [Related]
5. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.
McKinnon C; De Snoo ML; Gondard E; Neudorfer C; Chau H; Ngana SG; O'Hara DM; Brotchie JM; Koprich JB; Lozano AM; Kalia LV; Kalia SK
Acta Neuropathol Commun; 2020 Feb; 8(1):17. PubMed ID: 32059750
[TBL] [Abstract][Full Text] [Related]
6. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
[TBL] [Abstract][Full Text] [Related]
7. Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons.
Wu J; Xie H
Artif Cells Nanomed Biotechnol; 2016; 44(2):690-4. PubMed ID: 25386730
[TBL] [Abstract][Full Text] [Related]
8. Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death.
Sun F; Anantharam V; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
J Pharmacol Exp Ther; 2005 Oct; 315(1):69-79. PubMed ID: 15987830
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A and MnTMPyP Alleviate α-Synuclein Expression and Aggregation in Cypermethrin-Induced Parkinsonism.
Agrawal S; Dixit A; Singh A; Tripathi P; Singh D; Patel DK; Singh MP
Mol Neurobiol; 2015 Dec; 52(3):1619-1628. PubMed ID: 25370934
[TBL] [Abstract][Full Text] [Related]
10. L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells.
Yoshimoto Y; Nakaso K; Nakashima K
FEBS Lett; 2005 Feb; 579(5):1197-202. PubMed ID: 15710413
[TBL] [Abstract][Full Text] [Related]
11. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glutathione S-transferase-pi triggers c-jun N-terminal kinase-dependent neuronal death in Zn-induced Parkinsonism.
Chauhan AK; Mittra N; Singh BK; Singh C
Mol Cell Biochem; 2019 Feb; 452(1-2):95-104. PubMed ID: 30076580
[TBL] [Abstract][Full Text] [Related]
13. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
14. L-dopa increases α-synuclein DNA methylation in Parkinson's disease patients in vivo and in vitro.
Schmitt I; Kaut O; Khazneh H; deBoni L; Ahmad A; Berg D; Klein C; Fröhlich H; Wüllner U
Mov Disord; 2015 Nov; 30(13):1794-801. PubMed ID: 26173746
[TBL] [Abstract][Full Text] [Related]
15. A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease.
Giorgi FS; Bandettini di Poggio A; Battaglia G; Pellegrini A; Murri L; Ruggieri S; Paparelli A; Fornai F
J Neural Transm Suppl; 2006; (70):105-9. PubMed ID: 17017516
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-proteasome system and Parkinson's diseases.
Betarbet R; Sherer TB; Greenamyre JT
Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 Directs Microglial Activation-Mediated Inflammation and Oxidative Stress Leading to Intrinsic Apoptosis in Zn-Induced Parkinsonism.
Chauhan AK; Mittra N; Patel DK; Singh C
Mol Neurobiol; 2018 Mar; 55(3):2162-2173. PubMed ID: 28290146
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and B-cell Lymphoma-2 Associated X Protein Regulate Zinc-Induced Apoptotic Degeneration of Rat Nigrostriatal Dopaminergic Neurons.
Chauhan AK; Mittra N; Kumar V; Patel DK; Singh C
Mol Neurobiol; 2016 Oct; 53(8):5782-95. PubMed ID: 26497033
[TBL] [Abstract][Full Text] [Related]
20. L-DOPA regulates α-synuclein accumulation in experimental parkinsonism.
Deffains M; Canron MH; Teil M; Li Q; Dehay B; Bezard E; Fernagut PO
Neuropathol Appl Neurobiol; 2021 Jun; 47(4):532-543. PubMed ID: 33275784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]